WO2018122057A1 - Procédé d'isolement de lipides à partir d'une biomasse contenant des lipides - Google Patents
Procédé d'isolement de lipides à partir d'une biomasse contenant des lipides Download PDFInfo
- Publication number
- WO2018122057A1 WO2018122057A1 PCT/EP2017/083712 EP2017083712W WO2018122057A1 WO 2018122057 A1 WO2018122057 A1 WO 2018122057A1 EP 2017083712 W EP2017083712 W EP 2017083712W WO 2018122057 A1 WO2018122057 A1 WO 2018122057A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- suspension
- hours
- biomass
- cells
- pufas
- Prior art date
Links
- 239000002028 Biomass Substances 0.000 title claims abstract description 101
- 150000002632 lipids Chemical class 0.000 title claims abstract description 53
- 238000000034 method Methods 0.000 title claims abstract description 47
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims abstract description 68
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 138
- 239000000725 suspension Substances 0.000 claims description 101
- 238000000855 fermentation Methods 0.000 claims description 28
- 230000004151 fermentation Effects 0.000 claims description 28
- 230000002934 lysing effect Effects 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 26
- 150000003839 salts Chemical class 0.000 claims description 22
- 229910052799 carbon Inorganic materials 0.000 claims description 19
- 238000000926 separation method Methods 0.000 claims description 18
- 239000003960 organic solvent Substances 0.000 claims description 15
- 238000006386 neutralization reaction Methods 0.000 claims description 14
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 10
- 241001467333 Thraustochytriaceae Species 0.000 claims description 10
- 238000001704 evaporation Methods 0.000 claims description 10
- 230000008020 evaporation Effects 0.000 claims description 10
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 claims description 9
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 8
- 239000000920 calcium hydroxide Substances 0.000 claims description 8
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 8
- 241000233671 Schizochytrium Species 0.000 claims description 7
- 238000003306 harvesting Methods 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 5
- 241000233866 Fungi Species 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 claims description 3
- 241000195493 Cryptophyta Species 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims description 3
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 3
- 150000004679 hydroxides Chemical group 0.000 claims description 3
- HQRPHMAXFVUBJX-UHFFFAOYSA-M lithium;hydrogen carbonate Chemical compound [Li+].OC([O-])=O HQRPHMAXFVUBJX-UHFFFAOYSA-M 0.000 claims description 3
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 3
- 239000001095 magnesium carbonate Substances 0.000 claims description 3
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 3
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 3
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 3
- 239000011736 potassium bicarbonate Substances 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 235000011181 potassium carbonates Nutrition 0.000 claims description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 2
- 241000914635 Phylus Species 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 94
- 239000003921 oil Substances 0.000 description 76
- 235000019198 oils Nutrition 0.000 description 76
- 235000011121 sodium hydroxide Nutrition 0.000 description 44
- 238000012360 testing method Methods 0.000 description 28
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 26
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 21
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 20
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 19
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 18
- 235000010633 broth Nutrition 0.000 description 17
- 102000004190 Enzymes Human genes 0.000 description 15
- 108090000790 Enzymes Proteins 0.000 description 15
- 229940088598 enzyme Drugs 0.000 description 15
- 238000003756 stirring Methods 0.000 description 14
- 239000012071 phase Substances 0.000 description 13
- 239000011780 sodium chloride Substances 0.000 description 13
- 238000005119 centrifugation Methods 0.000 description 11
- 238000001035 drying Methods 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 10
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 150000003841 chloride salts Chemical class 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000005469 granulation Methods 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 150000003626 triacylglycerols Chemical class 0.000 description 6
- 102000005158 Subtilisins Human genes 0.000 description 5
- 108010056079 Subtilisins Proteins 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- -1 fatty acid esters Chemical class 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000003495 polar organic solvent Substances 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 235000017550 sodium carbonate Nutrition 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108010059820 Polygalacturonase Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 241001466451 Stramenopiles Species 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000593 degrading effect Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 3
- 229940012843 omega-3 fatty acid Drugs 0.000 description 3
- 239000006014 omega-3 oil Substances 0.000 description 3
- 238000005185 salting out Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241001306132 Aurantiochytrium Species 0.000 description 2
- 241000219193 Brassicaceae Species 0.000 description 2
- 102000005575 Cellulases Human genes 0.000 description 2
- 108010084185 Cellulases Proteins 0.000 description 2
- 108010022172 Chitinases Proteins 0.000 description 2
- 102000012286 Chitinases Human genes 0.000 description 2
- 241001117772 Elaeagnaceae Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 2
- 241000220485 Fabaceae Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 241001491666 Labyrinthulomycetes Species 0.000 description 2
- 241001306135 Oblongichytrium Species 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108010030975 Polyketide Synthases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 241000223252 Rhodotorula Species 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 241000233675 Thraustochytrium Species 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 102000016679 alpha-Glucosidases Human genes 0.000 description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 108010093305 exopolygalacturonase Proteins 0.000 description 2
- 239000011552 falling film Substances 0.000 description 2
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 235000014380 magnesium carbonate Nutrition 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 125000001477 organic nitrogen group Chemical group 0.000 description 2
- 238000009928 pasteurization Methods 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000000935 solvent evaporation Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 241000003610 Aplanochytrium Species 0.000 description 1
- 241000178280 Aureococcus Species 0.000 description 1
- 241000206761 Bacillariophyta Species 0.000 description 1
- 108700038091 Beta-glucanases Proteins 0.000 description 1
- 102100032487 Beta-mannosidase Human genes 0.000 description 1
- 241001138693 Botryochytrium Species 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000011331 Brassica Nutrition 0.000 description 1
- 235000005637 Brassica campestris Nutrition 0.000 description 1
- 244000178993 Brassica juncea Species 0.000 description 1
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 101000898643 Candida albicans Vacuolar aspartic protease Proteins 0.000 description 1
- 101000898783 Candida tropicalis Candidapepsin Proteins 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102100037328 Chitotriosidase-1 Human genes 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 241000384555 Chromulinales Species 0.000 description 1
- 241000534675 Chrysomeridales Species 0.000 description 1
- 101000898784 Cryphonectria parasitica Endothiapepsin Proteins 0.000 description 1
- 241001527609 Cryptococcus Species 0.000 description 1
- 102000005927 Cysteine Proteases Human genes 0.000 description 1
- 108010005843 Cysteine Proteases Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000146404 Developayella Species 0.000 description 1
- 241001494734 Dictyochales Species 0.000 description 1
- 241000199914 Dinophyceae Species 0.000 description 1
- 241000989765 Diplophrys Species 0.000 description 1
- 241001508399 Elaeagnus Species 0.000 description 1
- 239000004258 Ethoxyquin Substances 0.000 description 1
- 241000224472 Eustigmatophyceae Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 102100028496 Galactocerebrosidase Human genes 0.000 description 1
- 108010093031 Galactosidases Proteins 0.000 description 1
- 102000002464 Galactosidases Human genes 0.000 description 1
- 108010042681 Galactosylceramidase Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102100022624 Glucoamylase Human genes 0.000 description 1
- 108050008938 Glucoamylases Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010017544 Glucosylceramidase Proteins 0.000 description 1
- 102000004547 Glucosylceramidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 108010000540 Hexosaminidases Proteins 0.000 description 1
- 102000002268 Hexosaminidases Human genes 0.000 description 1
- 241001466486 Hibberdiales Species 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- 108050009363 Hyaluronidases Proteins 0.000 description 1
- 241001306467 Hydrurales Species 0.000 description 1
- 108010003381 Iduronidase Proteins 0.000 description 1
- 102000004627 Iduronidase Human genes 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000003482 Japonochytrium Species 0.000 description 1
- 241001149698 Lipomyces Species 0.000 description 1
- 102000005741 Metalloproteases Human genes 0.000 description 1
- 108010006035 Metalloproteases Proteins 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 241000233654 Oomycetes Species 0.000 description 1
- 241001138695 Parietichytrium Species 0.000 description 1
- 241000472328 Parmales Species 0.000 description 1
- 108010029182 Pectin lyase Proteins 0.000 description 1
- 241001494726 Pedinellales Species 0.000 description 1
- 241001494851 Pelagococcus Species 0.000 description 1
- 241001494897 Pelagomonas Species 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 101710184309 Probable sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- 241001518925 Raphidophyceae Species 0.000 description 1
- 241000520590 Reticulosphaera Species 0.000 description 1
- 241000264828 Rhizochromulinales Species 0.000 description 1
- 101000933133 Rhizopus niveus Rhizopuspepsin-1 Proteins 0.000 description 1
- 101000910082 Rhizopus niveus Rhizopuspepsin-2 Proteins 0.000 description 1
- 101000910079 Rhizopus niveus Rhizopuspepsin-3 Proteins 0.000 description 1
- 101000910086 Rhizopus niveus Rhizopuspepsin-4 Proteins 0.000 description 1
- 101000910088 Rhizopus niveus Rhizopuspepsin-5 Proteins 0.000 description 1
- 101000898773 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Saccharopepsin Proteins 0.000 description 1
- 241000193082 Sarcinochrysidales Species 0.000 description 1
- 241000598397 Schizochytrium sp. Species 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 241001138689 Sicyoidochytrium Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 102400000472 Sucrase Human genes 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 101710112652 Sucrose-6-phosphate hydrolase Proteins 0.000 description 1
- DRHKJLXJIQTDTD-OAHLLOKOSA-N Tamsulosine Chemical compound CCOC1=CC=CC=C1OCCN[C@H](C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1 DRHKJLXJIQTDTD-OAHLLOKOSA-N 0.000 description 1
- 102000035100 Threonine proteases Human genes 0.000 description 1
- 108091005501 Threonine proteases Proteins 0.000 description 1
- 241000223230 Trichosporon Species 0.000 description 1
- 241001491678 Ulkenia Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000235013 Yarrowia Species 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 108010061314 alpha-L-Fucosidase Proteins 0.000 description 1
- 102000012086 alpha-L-Fucosidase Human genes 0.000 description 1
- 108010012864 alpha-Mannosidase Proteins 0.000 description 1
- 102000019199 alpha-Mannosidase Human genes 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010055059 beta-Mannosidase Proteins 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 108010057052 chitotriosidase Proteins 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- QBWCMBCROVPCKQ-UHFFFAOYSA-N chlorous acid Chemical compound OCl=O QBWCMBCROVPCKQ-UHFFFAOYSA-N 0.000 description 1
- 229940077239 chlorous acid Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000009882 destearinating Methods 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 238000002036 drum drying Methods 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 235000019285 ethoxyquin Nutrition 0.000 description 1
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 1
- 229940093500 ethoxyquin Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- UQSQSQZYBQSBJZ-UHFFFAOYSA-N fluorosulfonic acid Chemical compound OS(F)(=O)=O UQSQSQZYBQSBJZ-UHFFFAOYSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 238000004442 gravimetric analysis Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007603 infrared drying Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000003505 mutagenic effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 150000002903 organophosphorus compounds Chemical class 0.000 description 1
- 238000010525 oxidative degradation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- PNGLEYLFMHGIQO-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methoxyanilino)-2-hydroxypropane-1-sulfonate;dihydrate Chemical compound O.O.[Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC=CC(OC)=C1 PNGLEYLFMHGIQO-UHFFFAOYSA-M 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 108010075550 termamyl Proteins 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- QGYZLVSWEOXOFT-UHFFFAOYSA-N tert-butyl(hydroxy)azanium;acetate Chemical compound CC(O)=O.CC(C)(C)NO QGYZLVSWEOXOFT-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 150000003735 xanthophylls Chemical class 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/10—Production of fats or fatty oils from raw materials by extracting
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
- A23D9/02—Other edible oils or fats, e.g. shortenings or cooking oils characterised by the production or working-up
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B1/00—Production of fats or fatty oils from raw materials
- C11B1/12—Production of fats or fatty oils from raw materials by melting out
Definitions
- the current invention relates to a method of isolating polyunsaturated fatty acids containing lipids from a lipids containing biomass.
- PUFAs polyunsaturated fatty acids
- PUFAs containing lipids are of high interest in the feed, food and pharmaceutical industry. Due to overfishing there is a high need for alternative sources for PUFAs containing lipids besides fish oil. It turned out that besides certain yeast and algal strains in particular microalgal cells like those of the order Thraustochytriales are a very good source for PUFAs containing lipids.
- a first subject of the current invention is a method of isolating a polyunsaturated fatty acids (PUFAs) containing lipid from a biomass, comprising the following steps:
- TDM total dry matter
- a particular subject of the current invention is a method of isolating a
- polyunsaturated fatty acids PUFAs
- PUFAs polyunsaturated fatty acids
- TDM total dry matter
- a temperature of 20°C to below 80°C preferably a temperature of 25°C to below 60°C, more preferably 25°C to 58°C, in particular 30 to 55°C, above all a temperature of 30°C to 50°C;
- a further particular subject of the current invention is a method of isolating a polyunsaturated fatty acids (PUFAs) containing lipid from a biomass, comprising the following steps: a) Providing a suspension of a biomass comprising cells which contain a PUFAs containing lipid;
- TDM total dry matter
- a further subject of the current invention is a method of isolating a polyunsaturated fatty acids (PUFAs) containing lipid from a biomass, comprising the following steps: a) Providing a suspension of a biomass comprising cells which contain a PUFAs containing lipid;
- TDM total dry matter
- a further subject of the current invention is a method of isolating a polyunsaturated fatty acids (PUFAs) containing lipid from a biomass, comprising the following steps: a) Providing a suspension of a biomass comprising cells which contain a PUFAs containing lipid;
- TDM total dry matter
- the pH is according to the invention preferably kept in step (e) below 11.5, more preferably below 1 1, more preferably below 10.5, in particular in the range of 8 to 11.5, more preferably in the range of 9 to 11 , in particular in the range of 10 to 11. This is realized by adding the base in step (e) not at once, but either continuously or step by step, so that exceeding the indicated pH values can be avoided.
- the steps (d) and (e) lead to the breaking of the emulsion as contained in the suspension into an oil containing light phase and a water, cell debris and salts containing heavy phase.
- This breaking of the emulsion is also called “demulsification" in the context of this application.
- the suspension is continuously mixed by using a stirrer and/or an agitator.
- steps (d) and/or (e) preferably low shear agitation and/or axial- flow agitation is applied, in particular as disclosed in WO
- Impellers suitable for agitating prior and during steps (d) and/or (e) include in particular straight blade impellers, Rushton blade impellers, axial flow impellers, radial flow impellers, concave blade disc impellers, high- efficiency impellers, propellers, paddles, turbines and combinations thereof.
- base equivalent takes account of the fact that not only monovalent, but also bi- or multivalent bases do exist and can be used according to the invention.
- a bivalent base is used instead or in addition to a monovalent base
- only the half molar amount of this bivalent base has to be used to realize the same amount of base equivalents in comparison to the amount of monovalent base which would have to be used; in case a trivalent base is used, then only a third of the molar amount of monovalent base has to be used; etc.
- a monovalent base like sodium hydroxide
- the amount of base equivalents is identical to the amount of base.
- the weight amount of base can easily be calculated basing on the molar amount by making use of the molar weight of the base. For example, in case of the very preferred base sodium hydroxide the molar weight equals to 40 g/mol. That means that one mole of sodium hydroxide corresponds to 40 g of sodium hydroxide.
- Preferred bases as used according to the invention are selected from hydroxides, in particular sodium hydroxide, lithium hydroxide, potassium hydroxide, and/or calcium hydroxide, carbonates, in particular sodium carbonate, potassium carbonate, and/or magnesium carbonate, and/or bicarbonates, in particular lithium bicarbonate, sodium bicarbonate, and/or potassium bicarbonate.
- the base used according to the invention is only or almost only sodium hydroxide.
- the bases are preferably used in liquid form, in particular as concentrated solutions, wherein the concentration of base in the solution is preferably in the range of 10 to 60 wt.-%, in particular in the range of 20 to 50 wt.-%.
- a lysing step is carried out.
- the lysing step can be omitted, if - for example due to the fermentation conditions as applied - the cells or a big part thereof is already lysed or easily breakable in one of the following steps of the procedure without any explicit lysing step.
- Lysing of the cells of the biomass according to step (b) can be carried out by methods as known to those skilled in the art, in particular enzymatically, mechanically, physically, or chemically, or by applying combinations thereof. Depending on the time of exposure and/or the degree of force applied, a composition comprising only lysed cells or a composition comprising a mixture of cell debris and intact cells may be obtained.
- the term "lysed lipids containing biomass” insofar relates to a suspension which contains water, cell debris and oil as set free by the cells of the biomass, but beyond that may also comprise further components, in particular salts, intact cells, further contents of the lysed cells as well as components of a fermentation medium, in particular nutrients.
- only small amounts of intact cells in particular less than 20 %, preferably less than 10 %, more preferably less than 5 % (relating to the total number of intact cells as present before lysing the cells of the biomass) are present in the lysed biomass after the step of lysing the cells.
- Lysing of the cells may be realized for example by utilizing a French cell press, sonicator, homogenizer, microfluidizer, ball mill, rod mill, pebble mill, bead mill, high pressure grinding roll, vertical shaft impactor, industrial blender, high shear mixer, paddle mixer, and/or polytron homogenizer.
- lysing of the cells comprises an enzymatic treatment of the cells by applying a cell- wall degrading enzyme.
- the cell-wall degrading enzyme is preferably selected from proteases, cellulases (e.g., Cellustar CL (Dyadic), Fibrezyme G2000 (Dyadic), Celluclast (Novozymes), Fungamyl (Novozymes), Viscozyme L (Novozymes)), hemicellulases, chitinases, pectinases (e.g., Pectinex (Novozymes)), sucrases, maltases, lactases, alpha- glucosidases, beta-glucosidases, amylases (e.g., Alphastar Plus (Dyadic); Termamyl (Novozymes)), lysozymes, neuraminidases, galactosidases, alpha-mannosidases, glucuronidases, hyaluronidases, pullulanases, glucocerebro
- the protease may be selected from serine proteases, threonine proteases, cysteine proteases, aspartate proteases, metalloproteases, glutamic acid proteases, alcalases (subtilisins), and combinations thereof.
- the chitinase may be a chitotriosidase.
- the pectinase may be selected from pectolyases, pectozymes,
- the adequate pH for utilizing the enzyme depends on the pH optimum of the enzyme.
- an enzyme with a pH optimum of between 7.0 and 8.0, in particular of about 7.5, is used, so that the pH applied in this step is from 7.0 to 8.0, preferably from 7.3 to 7.7.
- a preferred enzyme which can be used in this pH range is an alcalase.
- the enzyme is preferably added as a concentrated enzyme solution, preferably in an amount of 0.01 to 1.5 wt.-%, more preferably in an amount of 0.03 to 1.0 wt.-%, above all in an amount of 0.05 to 0.5 wt.-%, relating to the amount of concentrated enzyme solution as added in relation to the total amount of the suspension after addition of the concentrated enzyme solution.
- lysing of the cells is carried out as follows: i) Heating the suspension of (a) to a temperature of between 50°C and 70°C,
- the enzyme can be added before or after heating up the suspension and/or before or after adjusting the pH. In the same way heating up of the suspension can be carried out before or after adjusting the pH. - But in a preferred embodiment, the enzyme is added after heating up of the suspension and after adjusting the pH, if adjusting of the pH is necessary, at all. - In a very preferred embodiment all measures are carried out more or less simultaneously.
- the suspension is continuously mixed by using a stirrer and/or an agitator.
- the demulsification is carried out with a suspension having a dry matter content of 20 to 60 wt.-%, preferably 25 to 60 wt.%, in particular 30 to 55 wt.- % or 30 to 45 wt.-%.
- a suspension having a dry matter content of 20 to 60 wt.-%, preferably 25 to 60 wt.%, in particular 30 to 55 wt.- % or 30 to 45 wt.-%.
- This can be realized by either providing a suspension with an appropriately high biomass in step (a) or by concentrating the suspension, in particular after lysing the cells of the biomass.
- the suspension is concentrated to a total dry matter content of 20 to 60 wt.-%, more preferably 25 to 60 wt.-%, in particular 30 to 55 wt.-%, above all 30 to 50 wt.-% or 30 to 45 wt.-%.
- Concentration of the suspension is preferably carried out by evaporation of water at a temperature not higher than 100°C, preferably 70°C to 100°C, more preferably 80°C to 90°C, until a total dry matter content of 20 to 60 wt.-% more preferably 25 to 60 wt.-%, in particular 30 to 55 wt.-% or 30 to 45 wt.-%, is reached.
- Concentration of the suspension is preferably carried out in a forced circulation evaporator (for example available from GEA, Germany) to allow fast removal of the water.
- concentration might be carried out by falling film evaporation, thin film evaporation and/or rotary evaporation.
- adjusting the pH value can be carried out according to the invention by using either bases or acids as known to those skilled in the art. Decreasing of the pH can be carried out in particular by using organic or inorganic acids like sulfuric acid, nitric acid, phosphoric acid, boric acid, hydrochloric acid, hydrobromic acid, perchloric acid, hypochlorous acid, chlorous acid, fluorosulfuric acid, hexafluorophosphoric acid, acetic acid, citric acid, formic acid, or combinations thereof.
- hydrochloric acid is the preferred substance for decreasing the pH value.
- organic or inorganic bases like hydroxides, in particular sodium hydroxide, lithium hydroxide, potassium hydroxide, and/or calcium hydroxide, carbonates, in particular sodium carbonate, potassium carbonate, or magnesium carbonate, and/or bicarbonates, in particular lithium bicarbonate, sodium bicarbonate, and/or potassium bicarbonate.
- the acids and bases are preferably used in liquid form, in particular as concentrated solutions, wherein the concentration of acid or base in the solution is preferably in the range of 10 to 55 wt.-%, in particular in the range of 20 to 50 wt.-%.
- sulfuric acid is preferably used also in concentrated form.
- the method according to the invention preferably comprises as a further step the harvesting of the PUFAs containing lipid from the demulsified composition as obtained in step (e).
- the harvesting of the PUFAs containing lipid preferably comprises neutralization of the demulsified suspension and subsequent separation of the thus obtained oil containing light phase from the water, salts, cell debris and residual oil containing heavy phase.
- Neutralization of the demulsified composition is preferably realized by adding an acid, preferably sulfuric acid, to adjust a pH value of 5.5 to 8.5, in particular 6.5 to 8.5, preferably 6.5 to 7.5 or 7.0 to 8.0. Before starting separation of the light phase from the heavy phase the neutralized composition may be stirred at this neutralized pH from several minutes up to several hours. - Neutralization of the demulsified composition is only necessary in this embodiment for sure, if the demulsified composition as obtained according to step (e) of the methods of the invention has a pH value outside of this range.
- Separation of the oil containing light phase from the water, salts and cell debris containing heavy phase is preferably realized by mechanical means and preferably at a temperature of 60-90°C, more preferably 70-80°C, and preferably at a pH value of 6-9, more preferably 7- 8.5.
- Mechanical means refers in particular to filtration and centrifugation methods as known to those skilled in the art.
- the PUFAs containing oil thus obtained can further be worked up by applying methods as known to those skilled in the art, in particular refining, bleaching, deodorizing and/or winterizing.
- a particular advantage of the method of the current invention is that it can be carried out without the use of any organic solvent, in particular without the use of any polar or non- polar organic solvent.
- no or only little amounts of organic solvents are used for isolating the PUFAs containing oil from the biomass.
- Typical organic solvents are hexane and ethanol.
- less than 2 wt.-% non-polar organic solvents are used, more preferably less than 1, 0.5 or 0.1 wt.-%.
- no non-polar organic solvent is used, at all.
- organic solvents are used, in general, particularly preferred less than 1, 0.5 or 0.1 wt.-%. In a particularly very preferred embodiment of the invention no organic solvents are used, at all.
- a further advantage of the method of the current invention is that a very efficient separation of the oil from the remaining biomass can be realized without the addition of sodium chloride, which is normally used for salting out the oil from the biomass.
- the method can be carried out without the addition of chloride salts, at all, above all without the addition of any salts for salting out the oil.
- chloride salts in particular sodium chloride, might be present in the suspension due to the fermentation medium as used for growing of the biomass.
- no or only little amounts of sodium chloride are used for improving the oil isolation.
- less than 1 wt.-% of sodium chloride are used, more preferably less than 0.5 or 0.2 wt.-% of sodium chloride are used for isolating the oil from the biomass, above all less than 0.1 or 0.05 wt.-%, wherein the wt.-% relate to the total weight of the composition after addition of the sodium chloride.
- no or only little amounts of chloride salts are used for improving the oil isolation, at all.
- no or only little amounts of salts are used for improving the oil isolation, in general.
- the methods of the current invention allow a very efficient separation of the oil contained in the biomass from the cell-debris and other substances as contained in the suspension, in particular fermentation broth.
- preferably more than 80 wt.-%, in particular more than 90 wt.-% of the oil contained in the biomass can be separated from the biomass and isolated by applying very economic and sustainable conditions.
- Chloride refers to the amount of detectable chlorine.
- the amount of chlorine as present can be determined for example by elemental analysis according to DIN EN ISO 11885.
- the chlorine is present in the form of salts which are called “chlorides”.
- the content of chloride as mentioned according to the invention also called “chloride ions” - only refers to the amount of detectable chlorine, not to the amount of the complete chloride salt, which comprises besides the chloride ion also a cationic counterion.
- the total dry matter content (TDM) is preferably determined by gravimetric analysis. For doing that, a sample of the homogeneous suspension with a specific volume is weighed before and after freeze-drying. The remaining weight of the dried sample corresponds to the total dry matter as contained in that specific volume of the suspension.
- the yield of liberated oil is preferably determined by fatty acid methyl ester analysis (FAME).
- FAME fatty acid methyl ester analysis
- the lipids in the sample are first saponified with KOH. After that, the free fatty acids are methylated with MeOH.
- the methylated fatty acids can then be determined and quantified by gas chromatography by using an internal standard.
- the water, salts, residual oil and cell debris containing aqueous phase which is obtained as by-product in the oil harvesting step as described before, is converted into a dried biomass by drying the biomass to a total dry matter content of more than 90 wt.-%.
- Conversion of the water, salts, remaining oil and cell debris containing heavy phase, which is obtained as by-product in the oil harvesting step, into a dried biomass by drying the biomass to a total dry matter content of more than 90 wt.-% can be carried out in different ways.
- the transformation is carried out by concentration of the heavy phase to a dry matter content of 30-50 wt.-%, preferably 35-45 wt.-%, and subsequent spray granulation of the biomass by means of fluidized bed granulation.
- Concentration of the heavy phase to a dry matter content of 30-50 wt.-% is preferably carried out by solvent evaporation, in particular vacuum evaporation, and/or by using a rotary evaporator, a thin- film evaporator or a falling-film evaporator.
- solvent evaporation in particular vacuum evaporation, and/or by using a rotary evaporator, a thin- film evaporator or a falling-film evaporator.
- a useful alternative to solvent evaporation is reverse osmosis.
- an anti-caking agent in particular silica, preferably a hydrophobic or hydrophilic silica
- the suspension, in particular fermentation broth, comprising biomass as well as the silica are preferably sprayed into the particular drying zone.
- the biomass may be mixed with the anti-caking agent after the drying process.
- carboxymethylcellulose being a particulary preferred binding agent.
- the dried biomass is preferably stored or packed.
- the particulate biomass of the invention as well as the aqueous suspensions of the invention can be used in different ways. For example, they can be used in order to produce a foodstuff or feedstuff. Alternatively they may be used directly as foodstuff or feedstuff.
- a further subject matter of the present invention is therefore likewise a method for producing a feedstuff or foodstuff, in which a particulate biomass and/or an aqueous suspension according to the invention is used, and is preferably mixed with further feedstuff or foodstuff ingredients.
- the PUFAs containing cells of the biomass are preferably microbial cells or plant cells.
- the cells are capable of producing the PUFAs due to a polyketide synthase system.
- the polyketide synthase system may be an endogenous one or, due to genetic engineering, an exogenous one.
- the plant cells may in particular be selected from cells of the families Brassicaceae, Elaeagnaceae and Fabaceae.
- the cells of the family Brassicaceae may be selected from the genus Brassica, in particular from oilseed rape, turnip rape and Indian mustard; the cells of the family Elaeagnaceae may be selected from the genus Elaeagnus, in particular from the species Oleae europaea; the cells of the family Fabaceae may be selected from the genus Glycine, in particular from the species Glycine max.
- the microbial organisms which contain a PUFAs containing lipid are described extensively in the prior art.
- the cells used may, in this context, in particular be cells which already naturally produce PUFAs (polyunsaturated fatty acids); however, they may also be cells which, as the result of suitable genetic engineering methods or due to random mutagenesis, show an improved production of PUFAs or have been made capable of producing PUFAs, at all.
- the production of the PUFAs may be auxotrophic, mixotrophic or heterotrophic.
- the biomass preferably comprises cells which produce PUFAs heterotrophically.
- the cells according to the invention are preferably selected from algae, fungi, particularly yeasts, bacteria, or protists.
- the cells are more preferably microbial algae or fungi.
- Suitable cells of oil-producing yeasts are, in particular, strains of Yarrowia, Candida, Rhodotorula, Rhodosporidium, Cryptococcus, Trichosporon and Lipomyces.
- Suitable cells of oil-producing microalgae and algae-like microorganisms are, in particular, microorganisms selected from the phylum Stramenopiles (also called Heterokonta).
- the microorganisms of the phylum Stramenopiles may in particular be selected from the following groups of microorganisms: Hamatores, Proteromonads, Opalines,
- microalgae include the members of the green algae and dinoflagellates, including members of the genus
- the biomass according to the invention preferably comprises cells, and preferably consists essentially of such cells, of the taxon Labyrinthulomycetes (Labyrinthulea, net slime fungi, slime nets), in particular those from the family of Thraustochytriaceae.
- the family of the Thraustochytriaceae includes the genera Althomia, Aplanochytrium, Aurantiochytrium, Botryochytrium, Elnia, Japonochytrium, Oblongichytrium,
- the biomass particularly preferably comprises cells from the genera Aurantiochytrium, Oblongichytrium, Schizochytrium, or Thraustochytrium, above all from the genus
- the polyunsaturated fatty acid is preferably a highly-unsaturated fatty acid (HUFA).
- the cells present in the biomass are preferably distinguished by the fact that they contain at least 20% by weight, preferably at least 30%> by weight, in particular at least 35% by weight, of PUFAs, in each case based on cell dry matter.
- lipid includes phospholipids; free fatty acids; esters of fatty acids; triacylglycerols; sterols and sterol esters; carotenoids;
- xanthophylls e. g. oxycarotenoids
- hydrocarbons isoprenoid-derived compounds and other lipids known to one of ordinary skill in the art.
- lipid and “oil” are used interchangeably according to the invention.
- the majority of the lipids in this case is present in the form of triglycerides, with preferably at least 50% by weight, in particular at least 75% by weight and, in an especially preferred embodiment, at least 90% by weight of the lipids present in the cell being present in the form of triglycerides.
- polyunsaturated fatty acids PUFAs
- HUFAs highly-unsaturated fatty acids
- HUFAs are understood to mean fatty acids having at least four C-C double bonds.
- the PUFAs may be present in the cell in free form or in bound form.
- Examples of the presence in bound form are phospholipids and esters of the PUFAs, in particular monoacyl-, diacyl- and triacylglycerides.
- the majority of the PUFAs is present in the form of triglycerides, with preferably at least 50% by weight, in particular at least 75% by weight and, in an especially preferred embodiment, at least 90% by weight of the PUFAs present in the cell being present in the form of triglycerides.
- Preferred PUFAs are omega-3 fatty acids and omega-6 fatty acids, with omega-3 fatty acids being especially preferred.
- Preferred omega-3 fatty acids here are the
- eicosapentaenoic acid (EPA, 20:5 ⁇ -3), particularly the (5Z,8Z,1 lZ,14Z,17Z)-eicosa- 5,8,11 , 14, 17-pentaenoic acid, and the docosahexaenoic acid (DHA, 22:6 ⁇ -3), particularly the (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid.
- DHA docosahexaenoic acid
- cells in particular a
- Schizochytrium strain which produces a significant amount of EPA and DHA, simultaneously, wherein DHA is preferably produced in an amount of at least 20 wt.-%, preferably in an amount of at least 30 wt.-%, in particular in an amount of 30 to 50 wt.-%, and EPA is produced in an amount of at least 5 wt.-%, preferably in an amount of at least 10 wt.-%, in particular in an amount of 10 to 20 wt.-% (in relation to the total amount of lipid as contained in the cells, respectively).
- DHA and EPA producing Schizochytrium strains can be obtained by consecutive mutagenesis followed by suitable selection of mutant strains which demonstrate superior EPA and DHA production and a specific EPA:DHA ratio.
- Any chemical or nonchemical (e.g. ultraviolet (UV) radiation) agent capable of inducing genetic change to the yeast cell can be used as the mutagen.
- UV radiation ultraviolet
- These agents can be used alone or in combination with one another, and the chemical agents can be used neat or with a solvent.
- PTA-10208 PTA-10209, PTA-10210, or PTA-10211, PTA-10212, PTA-10213, PTA-10214, PTA-10215.
- the suspension of bio mass according to the present invention has preferably a bio mass density of at least 80 or 100 g/1, in particular a biomass density of 80 to 250 g/1, in particular 80 to 200 g/1, more preferably a biomass density of at least 120 or 140 g/1, in particular at least 160 or 180 g/1 (calculated as dry-matter content) and is preferably a fermentation broth.
- the suspension may be obtained by culturing and growing suitable cells in a fermentation medium under conditions whereby the PUFAs are produced by the microorganism.
- Methods for producing the biomass, in particular a biomass which comprises cells containing lipids, in particular PUFAs, particularly of the order Thraustochytriales, are described in detail in the prior art (see e.g.
- the production takes place by cells being cultured in a fermenter in the presence of a carbon source and of a nitrogen source, along with a number of additional substances like minerals that allow growth of the microorganisms and production of the PUFAs.
- biomass densities of more than 100 grams per litre and production rates of more than 0.5 gram of lipid per litre per hour may be attained.
- the process is preferably carried out in what is known as a fed-batch process, i.e. the carbon and nitrogen sources are fed in incrementally during the fermentation.
- lipid production may be induced by various measures, for example by limiting the nitrogen source, the carbon source or the oxygen content or combinations of these.
- the cells are grown until they reach a biomass density of at least 80 or 100 g/1, more preferably at least 120 or 140 g/1, in particular at least 160 or 180 g/1 (calculated as total dry matter content).
- a biomass density of at least 80 or 100 g/1, more preferably at least 120 or 140 g/1, in particular at least 160 or 180 g/1 (calculated as total dry matter content).
- the cells are fermented in a medium with low salinity, in particular so as to avoid corrosion. This can be achieved by using chlorine-free sodium salts as the sodium source instead of sodium chloride, such as, for example, sodium sulphate, sodium carbonate, sodium hydrogen carbonate or soda ash.
- chloride is used in the fermentation in amounts of less than 3 g/1, in particular less than 500 mg/1, especially preferably less than 100 mg/1.
- Suitable carbon sources are both alcoholic and non-alcoholic carbon sources.
- alcoholic carbon sources are methanol, ethanol and isopropanol.
- nonalcoholic carbon sources are fructose, glucose, sucrose, molasses, starch and corn syrup.
- Suitable nitrogen sources are both inorganic and organic nitrogen sources.
- inorganic nitrogen sources are nitrates and ammonium salts, in particular ammonium sulphate and ammonium hydroxide.
- organic nitrogen sources are amino acids, in particular glutamate, and urea.
- inorganic or organic phosphorus compounds and/or known growth-stimulating substances such as, for example, yeast extract or corn steep liquor, may also be added so as to have a positive effect on the fermentation.
- the cells are preferably fermented at a pH of 3 to 11, in particular 4 to 10, and preferably at a temperature of at least 20°C, in particular 20 to 40°C, especially preferably at least 30°C.
- a typical fermentation process takes up to approximately 100 hours.
- the cells may be pasteurized in order to kill the cells and to deactivate enzymes which might promote lipid degradation.
- the pasteurization is preferably effected by heating the biomass to a temperature of 50 to 121°C, preferably 50 to 70°C, for a period of 5 to 150 minutes, in particular 20 to 100 minutes.
- antioxidants may be added in order to protect the PUFAs present in the biomass from oxidative degradation.
- Preferred antioxidants in this context are BHT, BHA, TBHA, ethoxyquin, beta-carotene, vitamin E, in particular tocopherol, and vitamin C.
- the antioxidant if used, is preferably added in an amount of 0.001 to 0.1 wt.-%, preferably in an amount of 0.002 to 0.05 wt.-%, relating to the total amount of the fermentation broth after addition of the antioxidant.
- Example 1 Preparation of the suspension for use in the demulsification tests
- Example 5 Influence of the amount of added base equivalents on the liberation of the oil To test the significance of the amount of added base equivalents on the efficiency of the oil liberation from the biomass, the effect of addition of different amounts of caustic soda to the biomass with respect to the liberation of oil was tested. The ratio of base equivalents added to total dry matter is depicted in table 4 as well as the amount of oil as set free by the addition of the caustic soda. All experiments were carried out with one liter of
- TDM total dry matter content
- amount of base euqivalents and stirring speed on the liberation of the oil tests were carried out with enzymatically treated fermentation broths which were concentrated by forced circulation evaporation to a total dry matter content of either 25, 30 or 35 wt.-%. Tests were carried out in a stirring vessel BIOSTAT® B-DCU-Quad 2L (Sartorius, Germany). The volume of the concentrated suspensions as used in the tests was 1 L for each sample. In the tests the total amount of base equivalent added was varied from 5 to 7 wt.-%, while the demulsification was carried out either at 70, 80 or 90°C.
- Example 7 Influence of temperature on the liberation of the oil
- tests were carried out with enzymatically treated fermentation broths which were concentrated by forced circulation evaporation to a total dry matter content of 33 wt.-%. Tests were carried out in a stirring vessel BIOSTAT® B-DCU-Quad 2L (Sartorius, Germany). The volume of the concentrated suspensions as used in the tests was 1 L for each sample.
- the same total amount of base equivalent (6 wt.-% NaOH per TDM, i.e. 15 moles NaOH per 10 kg TDM) was added, while the demulsification was carried out either at 40, 50 or 90°C.
- the base equivalent was added in liquid form (20 wt.-% NaOH solution) in one shot at the beginning of the demulsification step. Demulsification took place at a stirrer speed of 300 rpm for 24 hours. After 24 hours the resulting composition was neutralized by adding sulfuric acid. After neutralization, a 50 g sample of the homogenized suspension was taken and separation of the cell debris was carried out by centrifugation at 13500 g. Subsequently the amount of EPA and DHA in the supernatant was determined. Table 6: Influence of the temperature on the yield of liberated oil
- the base equivalent was added in liquid form (20 wt.-% NaOH solution) in one shot at the beginning of the demulsification step. Demulsification took place at a stirrer speed of 300 rpm for 24 hours. After 24 hours the resulting composition was neutralized by adding sulfuric acid. After neutralization, a 50 g sample of the homogenized suspension was taken and separation of the cell debris was carried out by centrifugation at 13500 g. Subsequently the amount of EPA and DHA in the supernatant was determined.
- Enzymatically treated fermentation broths were concentrated by forced circulation evaporation to a total dry matter content of 34 wt.-%. Tests were carried out in a stirring vessel BIOSTAT® B-DCU-Quad 2L (Sartorius, Germany). The volume of the used concentrated suspensions was one liter for each sample. The demulsification was carried out at a temperature of 80°C and at an exposure time of 24 hours. The suspensions were stirred with 300 rpm. Either 10.6 moles base equivalents or 14.0 moles base equivalents of Ca(OH) 2 per 10 kg total dry matter were added to the suspension.
- Ca(OH) 2 was added stepwise in suspended form (20 wt.-% Ca(OH) 2 in water) in the course of the exposure, so that the pH value of the suspension never exceeded pH 9.5. After the incubation the resulting composition was neutralized by adding sulfuric acid. After neutralization, a 50 g sample of the homogenized suspension was taken and separation of the cell debris was carried out by centrifugation at 13500 g. Subsequently the amount of EPA and DHA in the supernatant was determined.
- Example 11 Demulsification without enzymatic treatment of the cells
- tests were carried out with fermentation broths which after pasteurisation were not treated enzymatically, but directly concentrated by forced circulation evaporation to a total dry matter content of 32.8 wt.-%.
- Tests were carried out in a stirring vessel BIOSTAT® B- DCU-Quad 2L (Sartorius, Germany). The volume of the used concentrated suspensions was 1 L for each sample. In each test the same total amount of base equivalent (6 wt.-% NaOH per TDM, i.e.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/473,805 US11352651B2 (en) | 2016-12-27 | 2017-12-20 | Method of isolating lipids from a lipids containing biomass |
CN201780087448.3A CN110462014A (zh) | 2016-12-27 | 2017-12-20 | 从含有脂质的生物质中分离脂质的方法 |
RU2019123315A RU2744913C2 (ru) | 2016-12-27 | 2017-12-20 | Способ выделения липидов из липидсодержащей биомассы |
CA3048289A CA3048289C (fr) | 2016-12-27 | 2017-12-20 | Procede d'isolement de lipides a partir d'une biomasse contenant des lipides |
ES17825501T ES2872009T3 (es) | 2016-12-27 | 2017-12-20 | Método de aislamiento de lípidos a partir de una biomasa que contiene lípidos |
EP17825501.4A EP3562925B1 (fr) | 2016-12-27 | 2017-12-20 | Procédé d'isolation de lipides à partir de biomasse contenant des lipides |
DK17825501.4T DK3562925T3 (da) | 2016-12-27 | 2017-12-20 | Fremgangsmåde til isolering af lipider fra en lipidholdig biomasse |
BR112019013418-2A BR112019013418B1 (pt) | 2016-12-27 | 2017-12-20 | Método de isolamento de lipídios a partir de uma biomassa contendo lipídios |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662439354P | 2016-12-27 | 2016-12-27 | |
US62/439,354 | 2016-12-27 | ||
EP17158286 | 2017-02-28 | ||
EP17158286.9 | 2017-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018122057A1 true WO2018122057A1 (fr) | 2018-07-05 |
Family
ID=58358344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2017/083712 WO2018122057A1 (fr) | 2016-12-27 | 2017-12-20 | Procédé d'isolement de lipides à partir d'une biomasse contenant des lipides |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2018122057A1 (fr) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019121752A1 (fr) * | 2017-12-20 | 2019-06-27 | Evonik Degussa Gmbh | Procédé d'isolement des lipides présents dans une biomasse contenant des lipides |
WO2019191544A1 (fr) * | 2018-03-30 | 2019-10-03 | Dsm Ip Assets B.V. | Procédé d'obtention d'une huile microbienne et procédé de réduction d'émulsion par maintien d'une faible concentration de glucide |
WO2020141206A1 (fr) * | 2019-01-03 | 2020-07-09 | Corbion Biotech Inc. | Procédé de fabrication d'une suspension de cellule lysée |
US20210100751A1 (en) * | 2018-02-02 | 2021-04-08 | Commonwealth Scientific and Industral Research Organisation | Protecting a bioactive and/or precursor thereof |
EA038909B1 (ru) * | 2018-02-15 | 2021-11-08 | Эвоник Оперейшенс ГмбХ | Способ выделения липидов из липидсодержащей биомассы |
WO2021254863A1 (fr) | 2020-06-18 | 2021-12-23 | Evonik Operations Gmbh | Procédé d'isolement de lipides à partir d'une biomasse contenant des lipides |
WO2021260087A1 (fr) | 2020-06-24 | 2021-12-30 | Fermentalg | Procédé de culture de microorganismes pour l'accumulation de lipides |
US11261400B2 (en) | 2017-09-05 | 2022-03-01 | Evonik Operations Gmbh | Method of separating lipids from a lysed lipids containing biomass |
US11414621B2 (en) | 2018-05-15 | 2022-08-16 | Evonik Operations Gmbh | Method of isolating lipids from a lipids containing biomass with aid of hydrophobic silica |
US11946017B2 (en) | 2016-07-13 | 2024-04-02 | Evonik Operations Gmbh | Method of separating lipids from a lysed lipids containing biomass |
US11976253B2 (en) | 2018-05-15 | 2024-05-07 | Evonik Operations Gmbh | Method of isolating lipids from a lysed lipids containing biomass by emulsion inversion |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991007498A1 (fr) | 1989-11-17 | 1991-05-30 | Phycotech, Inc. | Procede de production heterotrophique de produits microbiens a concentration elevee en acides gras omega-3 fortement insatures |
WO1994008467A1 (fr) | 1992-10-16 | 1994-04-28 | Omegatech, Inc. | Procede de production heterotrophe de produits microbiens a l'aide de concentrations elevees d'acides gras omega-3 fortement insatures |
WO1997036996A2 (fr) | 1996-03-28 | 1997-10-09 | Gist-Brocades B.V. | Procede pour la preparation d'une biomasse microbienne granulaire et isolation de composes interessants a partir de cette derniere |
WO1997037032A2 (fr) | 1996-03-28 | 1997-10-09 | Gist-Brocades B.V. | Preparation d'acide gras polyinsature microbien a partir d'huile contenant une biomasse pasteurisee |
WO2001053512A1 (fr) * | 2000-01-19 | 2001-07-26 | Omegatech, Inc. | Procede d'extraction sans solvant |
WO2001054510A1 (fr) | 2000-01-28 | 2001-08-02 | Omegatech, Inc. | Production amelioree de lipides contenant des acides gras polyenes au moyen de cultures a grande densite de microbes eucaryotes dans des fermenteurs |
EP1178118A1 (fr) * | 2000-08-02 | 2002-02-06 | Dsm N.V. | Isolation d'huiles microbiennes |
US20110124034A1 (en) * | 2009-11-25 | 2011-05-26 | Kuehnle Adelheid R | Enrichment of process feedstock |
US20120016145A1 (en) * | 2009-02-04 | 2012-01-19 | Eni S.P.A. | Process for the extraction of lipids from algal biomass |
WO2015095694A1 (fr) | 2013-12-20 | 2015-06-25 | Dsm Ip Assets B.V. | Procédés d'obtention d'huile microbienne à partir de cellules microbiennes |
CA2951001A1 (fr) * | 2014-06-17 | 2015-12-23 | Neste Oyj | Methode de recuperation de lipides a partir d'une biomasse microbienne |
WO2016050560A1 (fr) | 2014-10-02 | 2016-04-07 | Evonik Degussa Gmbh | Procédé de fabrication d'une biomasse granulée contenant une matière valorisable sensible à l'oxydation |
-
2017
- 2017-12-20 WO PCT/EP2017/083712 patent/WO2018122057A1/fr unknown
Patent Citations (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991007498A1 (fr) | 1989-11-17 | 1991-05-30 | Phycotech, Inc. | Procede de production heterotrophique de produits microbiens a concentration elevee en acides gras omega-3 fortement insatures |
WO1994008467A1 (fr) | 1992-10-16 | 1994-04-28 | Omegatech, Inc. | Procede de production heterotrophe de produits microbiens a l'aide de concentrations elevees d'acides gras omega-3 fortement insatures |
WO1997036996A2 (fr) | 1996-03-28 | 1997-10-09 | Gist-Brocades B.V. | Procede pour la preparation d'une biomasse microbienne granulaire et isolation de composes interessants a partir de cette derniere |
WO1997037032A2 (fr) | 1996-03-28 | 1997-10-09 | Gist-Brocades B.V. | Preparation d'acide gras polyinsature microbien a partir d'huile contenant une biomasse pasteurisee |
WO2001053512A1 (fr) * | 2000-01-19 | 2001-07-26 | Omegatech, Inc. | Procede d'extraction sans solvant |
US7732170B2 (en) | 2000-01-28 | 2010-06-08 | Martek Biosciences Corporation | Enhanced production of lipids containing polyenoic fatty acid by very hugh density cultures of eukaryotic microbes in fermentors |
WO2001054510A1 (fr) | 2000-01-28 | 2001-08-02 | Omegatech, Inc. | Production amelioree de lipides contenant des acides gras polyenes au moyen de cultures a grande densite de microbes eucaryotes dans des fermenteurs |
EP1178118A1 (fr) * | 2000-08-02 | 2002-02-06 | Dsm N.V. | Isolation d'huiles microbiennes |
US20120016145A1 (en) * | 2009-02-04 | 2012-01-19 | Eni S.P.A. | Process for the extraction of lipids from algal biomass |
US20110124034A1 (en) * | 2009-11-25 | 2011-05-26 | Kuehnle Adelheid R | Enrichment of process feedstock |
WO2015095694A1 (fr) | 2013-12-20 | 2015-06-25 | Dsm Ip Assets B.V. | Procédés d'obtention d'huile microbienne à partir de cellules microbiennes |
CA2951001A1 (fr) * | 2014-06-17 | 2015-12-23 | Neste Oyj | Methode de recuperation de lipides a partir d'une biomasse microbienne |
WO2016050560A1 (fr) | 2014-10-02 | 2016-04-07 | Evonik Degussa Gmbh | Procédé de fabrication d'une biomasse granulée contenant une matière valorisable sensible à l'oxydation |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11946017B2 (en) | 2016-07-13 | 2024-04-02 | Evonik Operations Gmbh | Method of separating lipids from a lysed lipids containing biomass |
US11261400B2 (en) | 2017-09-05 | 2022-03-01 | Evonik Operations Gmbh | Method of separating lipids from a lysed lipids containing biomass |
US11542220B2 (en) | 2017-12-20 | 2023-01-03 | Evonik Operations Gmbh | Method of isolating lipids from a lipids containing biomass |
WO2019121752A1 (fr) * | 2017-12-20 | 2019-06-27 | Evonik Degussa Gmbh | Procédé d'isolement des lipides présents dans une biomasse contenant des lipides |
US20210100751A1 (en) * | 2018-02-02 | 2021-04-08 | Commonwealth Scientific and Industral Research Organisation | Protecting a bioactive and/or precursor thereof |
EA038909B1 (ru) * | 2018-02-15 | 2021-11-08 | Эвоник Оперейшенс ГмбХ | Способ выделения липидов из липидсодержащей биомассы |
WO2019191544A1 (fr) * | 2018-03-30 | 2019-10-03 | Dsm Ip Assets B.V. | Procédé d'obtention d'une huile microbienne et procédé de réduction d'émulsion par maintien d'une faible concentration de glucide |
US11414621B2 (en) | 2018-05-15 | 2022-08-16 | Evonik Operations Gmbh | Method of isolating lipids from a lipids containing biomass with aid of hydrophobic silica |
US11976253B2 (en) | 2018-05-15 | 2024-05-07 | Evonik Operations Gmbh | Method of isolating lipids from a lysed lipids containing biomass by emulsion inversion |
WO2020141206A1 (fr) * | 2019-01-03 | 2020-07-09 | Corbion Biotech Inc. | Procédé de fabrication d'une suspension de cellule lysée |
WO2021254863A1 (fr) | 2020-06-18 | 2021-12-23 | Evonik Operations Gmbh | Procédé d'isolement de lipides à partir d'une biomasse contenant des lipides |
WO2021260087A1 (fr) | 2020-06-24 | 2021-12-30 | Fermentalg | Procédé de culture de microorganismes pour l'accumulation de lipides |
FR3111912A1 (fr) | 2020-06-24 | 2021-12-31 | Fermentalg | Procédé de culture de microorganismes pour l’accumulation de lipides |
EP3933016A1 (fr) | 2020-06-30 | 2022-01-05 | Evonik Operations GmbH | Procédé d'isolation de lipides à partir de biomasse contenant des lipides |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3562925B1 (fr) | Procédé d'isolation de lipides à partir de biomasse contenant des lipides | |
US11542220B2 (en) | Method of isolating lipids from a lipids containing biomass | |
AU2017297752B2 (en) | Method for isolating lipids from lipid-containing cells | |
WO2018122057A1 (fr) | Procédé d'isolement de lipides à partir d'une biomasse contenant des lipides | |
AU2017297760B2 (en) | Method of separating lipids from a lysed lipids containing biomass | |
US11976253B2 (en) | Method of isolating lipids from a lysed lipids containing biomass by emulsion inversion | |
EP3794097B1 (fr) | Procédé d'isolation de lipides à partir de biomasse contenant des lipides à l'aide de silice hydrophobe | |
US11946017B2 (en) | Method of separating lipids from a lysed lipids containing biomass | |
WO2019121752A1 (fr) | Procédé d'isolement des lipides présents dans une biomasse contenant des lipides | |
DK201970085A1 (en) | Method for isolating lipids from lipid-containing cells | |
EP3679114A1 (fr) | Procédé de séparation de lipides dans une biomasse contenant des lipides lysés | |
WO2019048327A1 (fr) | Procédé de séparation de lipides dans une biomasse contenant des lipides lysés | |
EP4168520A1 (fr) | Procédé d'isolement de lipides à partir d'une biomasse contenant des lipides | |
BR112019013418B1 (pt) | Método de isolamento de lipídios a partir de uma biomassa contendo lipídios |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17825501 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 3048289 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112019013418 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 2017825501 Country of ref document: EP Effective date: 20190729 |
|
ENP | Entry into the national phase |
Ref document number: 112019013418 Country of ref document: BR Kind code of ref document: A2 Effective date: 20190627 |